Interventional Oncology
Farshid Dayyani, MD, PhD (he/him/his)
Professor of Clinical Medicine
University of California Irvine
Disclosure(s): AstraZeneca: Consultant (Ongoing); Deciphera: Speaking and Teaching (Terminated, June 30, 2022); Eisai: Consultant (Ongoing); Exelixis: Consultant (Ongoing), Speaking and Teaching (Ongoing); Genentech: Consultant (Terminated, June 30, 2022); Ipsen: Speaking and Teaching (Ongoing); Natera: Speaking and Teaching (Terminated, November 30, 2021); Servier: Speaking and Teaching (Ongoing); Sirtex Medical: Speaking and Teaching (Ongoing)